FITLIFE BRANDS, INC. (FTLF) Form 10-K Annual Reports
FITLIFE BRANDS, INC. (FTLF) is a publicly traded company on the Nasdaq, categorized under SIC 2833 (Medicinal Chemicals & Botanical Products). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: FTLF
CIK: 1374328
Exchange: Nasdaq
SIC 2833: Medicinal Chemicals & Botanical Products
Fiscal Year End: 12/31
State: NV
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Weinberg & Company, P.A.
Auditor SinceSince 12/31/2022 12:00:00 AM
Lead Engagement PartnerJohn Lucas
Audit LocationLos Angeles, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-09-09 | 2026-09-09 | FORM 8-K | 0001437749-26-029979 | View SEC Doc Filr Page |
| 4 | 2026-09-02 | 2026-08-28 | 4 Filing | 0001942421-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-08-21 | 2026-08-19 | 4 Filing | 0002067544-26-000002 | View SEC Doc Filr Page |
| 8-K | 2026-08-13 | 2026-08-11 | FORM 8-K | 0001437749-26-027493 | View SEC Doc Filr Page |
| 10-Q | 2026-08-13 | 2026-06-30 | FORM 10-Q | 0001437749-26-027478 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-07 | — | SCHEDULE 13G/A Filing | 0001815572-26-000005 | View SEC Doc Filr Page |
| DEFA14A | 2026-06-26 | — | FORM DEFA14A | 0001437749-26-021807 | View SEC Doc Filr Page |
| DEFA14A | 2026-06-26 | — | FORM DEFA14A | 0001437749-26-021806 | View SEC Doc Filr Page |
| DEF 14A | 2026-06-26 | 2026-08-11 | FORM DEF 14A | 0001437749-26-021797 | View SEC Doc Filr Page |
| 8-K | 2026-05-22 | 2026-05-18 | FORM 8-K | 0001437749-26-018249 | View SEC Doc Filr Page |
| 4 | 2026-05-19 | 2026-05-15 | 4 Filing | 0002067752-26-000002 | View SEC Doc Filr Page |
| 8-K | 2026-05-14 | 2026-05-14 | FORM 8-K | 0001437749-26-016983 | View SEC Doc Filr Page |
| 10-Q | 2026-05-14 | 2026-03-31 | FORM 10-Q | 0001437749-26-016875 | View SEC Doc Filr Page |
| 10-K/A | 2026-04-21 | 2025-12-31 | FORM 10-K/A | 0001437749-26-012937 | View SEC Doc Filr Page |
| 4 | 2026-04-20 | 2026-01-15 | 4 Filing | 0001318798-26-000004 | View SEC Doc Filr Page |
| 5 | 2026-04-20 | 2025-12-31 | 5 Filing | 0001318798-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-04-14 | 2026-04-10 | 4 Filing | 0002033776-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-04-14 | 2026-04-10 | 4 Filing | 0001465378-26-000002 | View SEC Doc Filr Page |
| 8-K | 2026-04-07 | 2026-04-01 | FORM 8-K | 0001437749-26-011607 | View SEC Doc Filr Page |
| 8-K | 2026-04-01 | 2026-04-01 | FORM 8-K | 0001437749-26-010811 | View SEC Doc Filr Page |
| 10-K | 2026-03-31 | 2025-12-31 | FORM 10-K | 0001437749-26-010680 | View SEC Doc Filr Page |
| 8-K | 2025-12-10 | 2025-12-10 | FORM 8-K | 0001437749-25-037314 | View SEC Doc Filr Page |
| 8-K | 2025-11-13 | 2025-11-13 | FORM 8-K | 0001437749-25-034610 | View SEC Doc Filr Page |
| 10-Q | 2025-11-13 | 2025-09-30 | FORM 10-Q | 0001437749-25-034607 | View SEC Doc Filr Page |
| 8-K/A | 2025-10-20 | 2025-08-08 | FORM 8-K/A | 0001437749-25-031312 | View SEC Doc Filr Page |